Obstructive sleep apnea and cardiovascular comorbidities: A large epidemiologic study

Medicine (United States)

Volumn 93, Issue 9, 2014, Pages

  Gilat, Hanna ^a,b   Vinker, Shlomo ^b   Buda, Inon ^a,b   Soudry, Ethan ^a   Shani, Michal ^b,c   Bachar, Gideon ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c CLALIT HEALTH SERVICES   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL ABUSE; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; EARLY DIAGNOSIS; ELECTRONIC MEDICAL RECORD; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SLEEP DISORDERED BREATHING; SMOKING; SOCIAL STATUS;

CARDIOVASCULAR DISEASES; COMORBIDITY; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; ISRAEL; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84906713220     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000045     Document Type: Article

References (55)

1. Sleep related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep. 1999;22:667-689.
2. Sorajja D, Gami AS, Somers VK, et al. Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest. 2008;133:927-933. (Pubitemid 351536868)
3. Young T, Evans L, Finn L, et al. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep. 1997;20:705-706. (Pubitemid 27506200)
4. Somers VK, White DP, Amir R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). J Am Coll Cardiol. 2008;52:686-717.
5. Caples SM, Somers VK. Sleep disordered breathing and atrial fibrillation. Prog Cardiovasc Dis. 2009;51:411-415.
6. Chobanian AV, Bakaris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. J Am Med Assoc. 2003;289:2560-2572. (Pubitemid 37430158)
7. Haenjens P, Van Meerhaeghe A, Moscariello A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence of a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007;167:757-764.
8. Bazzano LA, Khan Z, Reynolds K, et al. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50:417-423. (Pubitemid 47205794)
9. Alajmi M, Mulgrew AT, Fox J, et al. Impact of continuous positive airway pressure therapy on blood pressure in obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung. 2007;185:67-72. (Pubitemid 46571874)
10. Deegan PC, McNicholas WT. Pathophysiology of obstructive sleep apnea. Eur Respir J. 1995;8:1161-1178.
11. Guilleminault C, Tikian A, Dement WC. The sleep apnea syndromes. Annu Rev Med. 1976;27:465-484.
12. Stadling JR, Philipson EA. Breathing disorders during sleep. Q J Med. 1986;58:3-18.
13. Reemers JE, DeGroot WJ, Sauerland EK, et al. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol Respirat Environ Exerc Physiol. 1978;44:931-938. (Pubitemid 9158239)
14. Hudgel DW, Hendricks C, Hamilton HB. Characteristics of the upper airway pressure-flow relationship during sleep. J Apl Physiol. 1988;64:1930-1935.
15. Gilat H, Shpitzer T, Guttman D, et al. Obstructive sleep apnea after radial forearm free flap reconstruction of the oral tongue. Laryngoscope. 2013;12:3223-3226.
16. Khayat R, Patt B, Hayes D. Obstructive sleep apnea: the new cardiovascular disease. Part 1: obstructive sleep apnea and the pathogenesis of vascular disease. Heart Fail Rev. 2009;14:143-153.
17. Arzt M, Kleiman J, Carrington M, et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med. 2006;166:1716-1722. (Pubitemid 44414458)
18. Arzt M, Young T, Peppard PE, et al. Dissociation of obstructive sleep apnea from hypersomnolence and obesity in patients with stroke. Stroke. 2010;41:e129-e134.
19. Kasai T, Floras JS, Bradley TD. Sleep apnea and cardiovascular disease. A bidirectional relationship. Circulation. 2012;126:1495-1510.
20. Sjostrom C, Lindberg E, Elmasry A, et al. Prevalence of sleep apnoea and snoring in hypertensive men: a population-based study. Thorax. 2002;57:602-607. (Pubitemid 34761762)
21. Logan AG, Peliikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001;1:2271-2277. (Pubitemid 33135251)
22. Pedrosa RP, Drager LF, Gonzaga CC, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58:811-817.
23. Logan AG, Tkacova R, Perlikowski SM, et al. Refractory hypertension and sleep apnea: effect of CPAP on blood pressure and baroreflex. Eur Respir J. 2003;21:241-247. (Pubitemid 36204537)
24. Brooks D, Horner RL, Kozar LF, et al. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest. 1997;99:106-109. (Pubitemid 27058300)
25. Fletcher EC, Lesske J, Behm R, et al. Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. J Appl Physiol. 1992;72:1978-1984.
26. Morgan BJ, Denahan T, Ebert TJ. Neurocirculatory consequences of negative intrathoracic pressure vs. asphyxia during voluntary apnea. J Appl Physiol. 1993;74:2969-2975. (Pubitemid 23201331)
27. Clavin AD, Somers VK. Obstructive sleep apnea and cardiovascular disease. Curr Opin Cardiol. 2009;24:516-520.
28. Somers VK, Dyken M, Clary M, et al. Sympathetic ceural mechanisms in obstructive sleep apnea. J Clin Investig. 1995;96:1897-1904.
29. Chin K, Oji M, Kita H, et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1996;153:1972-1976. (Pubitemid 26187928)
30. Rangrmark C, Hedner JA, Carlson JT, et al. Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients. Sleep. 1995;18:188-194.
31. von Kanel R, Loredo JS, Ancoli-Israel S, et al. Association between polysomnographic measures of disrupted sleep and prothrombotic factors. Chest. 2007;131:733-739. (Pubitemid 46446864)
32. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the sleep heart health study. Am J Respir Crit Care Med. 2001;163:19-25. (Pubitemid 32095247)
33. Adegunsove A, Ramachandran S. Ethiopathogenic mechanisms of pulmonary hypertension in sleep-related breathing disorders. Pulm Med. 2012;2012:273591.
34. Golbin JM, Somers VK, Caples SM. Obstructive sleep apnea, cardiovascular disease, and pulmonary hypertension. Proc Am Thor Soc. 2008;5:200-206. (Pubitemid 351237879)
35. Tuder RM, Abman SH, Braun T, et al. Development and pathology of pulmonary hypertension. J Am Coll Cardiol. 2009;54:s3-s9.
36. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med. 1991;115:343-349.
37. Wang H, Parker JD, Newton GE, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007;49:1625-1631. (Pubitemid 46551635)
38. Baranchuk A. Sleep apnea, cardiac arrhythmias, and conduction disorders. J Electrocardiol. 2012;45:508-512.
39. Baranchuk A, Simpson CS, Redfearn DP, et al. It's time to wake up! Sleep apnea and cardiac arrhythmias. Europace. 2008;10:666.
40. Hersi AS. Obstructive sleep apnea and cardiac arrhythmias. Ann Thorac Med. 2010;6:10.
41. Todd K, McIntyre WF, Baranchuk A. Obstructive sleep apnea and atrial fibrillation. Nat Sci Sleep. 2010;2:39.
42. Kannel WB, Wolf PA, Benjamin EJ. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82:2N.
43. Atwood CW, McCrory D, Garcia JGN, et al. Pulmonary artery hypertension and sleep-disordered breathing. Chest. 2004;126:72.
44. Yaggi KH, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. NEJM. 2005;353:2034-2041. (Pubitemid 41609096)
45. Marin JM, Carrizo SJ, Vincente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;65:1046-1053. (Pubitemid 40386782)
46. Melville NA. Average age at first stroke decreases in United States but not Italy. 2010. http://www.medscape.com/viewarticle/730149. Accessed July 20, 2014.
47. Tousignant P, Cosio MG, Levy RD, et al. Quality adjusted life years added by treatment of obstructive sleep apnea. Sleep. 1994;17:52-60. (Pubitemid 24103641)
48. Chin K, Ohi M, Kita H, et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1996;153:1972-1976. (Pubitemid 26187928)
49. Kato M, Roberts-Thomson P, Phillips BG, et al. Impairment of endothelium dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation. 2000;102:2607-2610.
50. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation. 2003;107:68-73. (Pubitemid 36070935)
51. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet. 2002;359:204-210. (Pubitemid 34113817)
52. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of Creactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003;107:1129-1134. (Pubitemid 36297204)
53. Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897-1904.
54. Diomedi M, Placidi F, Cupini LM, et al. Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment. Neurology. 1998;51:1051-1056. (Pubitemid 28473399)
55. http://www.stanford.edu/∼dement/epworth.html. Accessed August 10, 2012.